000 | 05183nam a22004454a 4500 | ||
---|---|---|---|
001 | vtls003165332 | ||
003 | MY-SjTCS | ||
005 | 20200226112134.0 | ||
006 | m u | ||
007 | cr cn||||||||| | ||
008 | 100712s2005 nyua sb 001 0 eng | ||
010 | _z 2004-022295 | ||
020 | _z0814408451 | ||
035 | _a(CaPaEBR)ebr10075614 | ||
039 | 9 |
_y201007121353 _zVLOAD |
|
040 |
_aCaPaEBR _cCaPaEBR |
||
050 | 1 | 4 |
_aRA418.5.M4 _bD49 2005eb |
082 | 0 | 4 |
_a610/.28 _222 |
100 | 1 | _aDeyo, Richard A. | |
245 | 1 | 0 |
_aHope or hype _h[electronic resource] : _bthe obsession with medical advances and the high cost of false promises / _cRichard A. Deyo, Donald L. Patrick. |
260 |
_aNew York : _bAmerican Management Association, _cc2005. |
||
300 |
_axvi, 335 p. : _bill. ; _c24 cm. |
||
504 | _aIncludes bibliographical references (p. [291]-326) and index. | ||
505 | 0 | _aCan there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. | |
505 | 0 | _aCan there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making. | |
529 | _aTSLHHL | ||
533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2009. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
650 | 0 |
_aMedical innovations _zUnited States _xEvaluation. |
|
650 | 0 |
_aMedical technology _zUnited States _xEvaluation. |
|
650 | 0 |
_aMedical care _xTechnological innovations _zUnited States _xEvaluation. |
|
650 | 0 |
_aMedical care _zUnited States _xEvaluation. |
|
650 | 0 |
_aMedical innovations _xEconomic aspects _zUnited States. |
|
650 | 0 |
_aMedical technology _zUnited States _xCost effectiveness. |
|
650 | 0 |
_aMedical care _xTechnological innovations _zUnited States _xCost effectiveness. |
|
650 | 0 |
_aMedical care, Cost of _zUnited States. |
|
655 | 7 |
_aElectronic books. _2local |
|
700 | 1 | _aPatrick, Donald L. | |
710 | 2 |
_aebrary, Inc. _925628 |
|
856 | 4 | 0 |
_uhttp://ezproxy.taylors.edu.my/login?url=http://site.ebrary.com/lib/taylorscollege/Doc?id=10075614 _zAn electronic book accessible through the World Wide Web; click to view |
999 |
_c90511 _d90511 |